ClouDr Group Ltd
HKEX:9955
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (0.1), the stock would be worth HK$-0.85 (221% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.1 | HK$0.7 |
0%
|
| 3-Year Average | 0.1 | HK$-0.85 |
-221%
|
| 5-Year Average | 0.1 | HK$-0.86 |
-223%
|
| Industry Average | 3.8 | HK$-28.35 |
-4 150%
|
| Country Average | 3.3 | HK$-24.76 |
-3 637%
|
Forward EV/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
C
|
ClouDr Group Ltd
HKEX:9955
|
410.9m HKD | -0.1 | -0.4 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
102.7B USD | 0.3 | 23.4 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.7B USD | 0.2 | 37.4 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.7B USD | 0.2 | 37.2 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
48.5B USD | 0.2 | 28.8 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.6B AUD | 2.9 | 35.1 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.8B CNY | 0.3 | 11 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.8B USD | 0.9 | 21.6 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
59.2B CNY | 1.7 | 20.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.8 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
57.5B HKD | 0 | 7.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.7 |
| Median | 3.3 |
| 70th Percentile | 6.2 |
| Max | 5 034 353.9 |
Other Multiples
ClouDr Group Ltd
Glance View
ClouDr Group Ltd is a CN-based company operating in Health Care Providers & Services industry. The company is headquartered in Hangzhou, Zhejiang and currently employs 1,407 full-time employees. The company went IPO on 2022-07-06. ClouDr Group Ltd is a China-based holding company principally engaged in the provision of medical services and products. The firm provides medical supplies and software-as-a-service (SaaS) products to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultations and prescriptions to patients. The firm's product portfolio consists of three major product or service categories. The in-hospital solution mainly includes hospital supplies sales, hospital SaaS and digital marketing services. The pharmacy solution mainly includes pharmacy supplies sales and pharmacy SaaS. The individual chronic condition management solution and others mainly include chronic condition products, premium membership services, as well as insurance brokerage services, advertisement agent services and others.
